OOIR: Observatory of International Research

Papers

(The TQCC of European Respiratory Review is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections	246
European Respiratory Review, list of peer reviewers 2021	183
European Respiratory Review, list of peer reviewers 2023	170
Occupation and SARS-CoV-2 in Europe: a review	119
Exacerbations of bronchiectasis	115
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	114
Reply to: “Nicotine or tobacco abstinence?”	112
Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective	96
New trends in pulmonary hypertension	94
Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis	81
The world of rare interstitial lung diseases	77
European Respiratory Review, list of peer reviewers 2022	76
Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework	76
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	75
“Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.” M. Kolb, B. Crestani and T.M. Maher.Eur Respir Rev2023; 32: 220206.	74
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	70
Preclinical models of maternal asthma and progeny outcomes: a scoping review	66
Ergonomics of bronchoscopy: good advice or a pain in the neck?	64
A critical interpretive synthesis of the lived experiences and health and patient-reported outcomes of people living with COPD who isolated during the COVID-19 pandemic	64
Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?	61
The role of telemonitoring in patients on home mechanical ventilation	57
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	55
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	54
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis	54
The epithelial era of asthma research: knowledge gaps and future direction for patient care	53

Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	53
Impact of exercise training on cognitive function in patients with COPD: a systematic review and meta-analysis of randomised controlled trials	53
Macrophages and the microbiome in chronic obstructive pulmonary disease	53
Sex and gender differences during the lung lifespan: unveiling a pivotal impact	51
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	50
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis	50
Interventions for the management of malignant pleural effusions: an updated network meta-analysis	48
Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis	47
ERS/EAACI statement on adherence to international adult asthma guidelines	47
Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery	46
The efficacy of immune checkpoint inhibitors in thoracic malignancies	44
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	44
“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	44
Does pulmonary rehabilitation address treatable traits? A systematic review	43
The risk of cardiovascular, cerebrovascular and thromboembolic events after community-acquired pneumonia among adults: a systematic literature review	43
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review	43
Interstitial pneumonia with autoimmune features: challenges and controversies	42
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health	42
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	41
Eosinophils and eosinophilic immune dysfunction in health and disease	41
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care	41
Exploring the 175-year history of spirometry and the vital lessons it can teach us today	39
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency	39
Growing from common ground: nontuberculous mycobacteria and bronchiectasis	38
Management ofMycobacterium aviumcomplex andMycobacterium abscessuspulmonary disease: therapeutic advances and emerging treatments	38
Lung transplantation for interstitial lung disease	36
Deep learning for pneumothorax diagnosis: a systematic review and meta-analysis	36
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	35
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis	35
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	35
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review	35
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?	34
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	34
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	34
Parasitic lung diseases	33
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	32
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review	32
Chronic lung diseases: entangled in extracellular matrix	32
Training in interventional pulmonology: the European and US perspective	32
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	32
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	31
Management of asthma exacerbations in the paediatric population: a systematic review	31
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries	31
Post-acute COVID-19 syndrome	31
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	30
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis	30
Epigenetics and sarcoidosis	30
20 years of neuromuscular electrical stimulation in COPD	29
Silicotuberculosis: a critical narrative review	29
Advance care planning in patients with respiratory failure	28

“Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis”. Diana P. Pozuelo-Carrascosa, Ángel Herráiz-Adillo, Celia	28
Correction to subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis	28
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	28
Impact of ageing and pregnancy on the minute ventilation/carbon dioxide production response to exercise	28
Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications	28
Developments in radiation techniques for thoracic malignancies	28
Bronchiectasis in Asia: a review of current status and challenges	27
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	27
“How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?”. G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.	27
Social determinants of advanced chronic respiratory interventions: a scoping review	27
The role of vascularity and the fibrovascular interface in interstitial lung diseases	26
Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis	26
Airway epithelium in lung transplantation: a potential actor for post-transplant complications?	26
Reference equations for oscillometry and their differences among populations: a systematic scoping review	26
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	26
“Noninvasive respiratory support after extubation: a systematic review and network meta-analysis”. A. Boscolo, T. Pettenuzzo, N. Sella, M. Zatta, M. Salvagno, M. Tassone, C. Pretto, A. Peralta, L. Mur	25
Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms	25
Surgical and bronchoscopic pulmonary function-improving procedures in lung emphysema	24
Inhaled corticosteroids for the treatment of COVID-19	24
The impact of lung surgery, with or without (neo-)adjuvant therapy, on physical functioning in patients with nonsmall cell lung cancer: a scoping review	23
Global respiratory health priorities at the beginning of the 21st century	23
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	23
The re-emerging role of linoleic acid in paediatric asthma	23
Common single nucleotide polymorphisms associated with idiopathic pulmonary fibrosis: a systematic review	23
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	22
From treatable traits to GETomics in airway disease: moving towards clinical practice	22
Patient-centred outcomes in severe asthma: fatigue, sleep, physical activity and work	22
Digital remote maintenance inhaler adherence interventions in COPD: a systematic review and meta-analysis	22
The role of heat shock protein 90 in idiopathic pulmonary fibrosis: state of the art	22
Lung stem cells and respiratory epithelial chimerism in transplantation	22
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis	21
Obesity, leptin and host defence ofStreptococcus pneumoniae: the case for more human research	21
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents	21
New developments in locally advanced nonsmall cell lung cancer	21
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	21